Annual Accounts Payable
$2.61 M
+$2.38 M+1033.04%
31 December 2021
Summary:
Concert Pharmaceuticals annual accounts payable is currently $2.61 million, with the most recent change of +$2.38 million (+1033.04%) on 31 December 2021. During the last 3 years, it has risen by +$2.38 million (+1033.04%).CNCE Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$2.75 M
+$1.38 M+100.66%
30 September 2022
Summary:
Concert Pharmaceuticals quarterly accounts payable is currently $2.75 million, with the most recent change of +$1.38 million (+100.66%) on 30 September 2022.CNCE Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNCE Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +1033.0% | +370.4% |
| 5 y5 years | +104.1% | +111.0% |
CNCE Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | at high | -0.3% |
Concert Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $2.75 M(+100.7%) |
| June 2022 | - | $1.37 M(-50.3%) |
| Mar 2022 | - | $2.75 M(+5.7%) |
| Dec 2021 | $2.61 M(+1033.0%) | $2.61 M(+346.2%) |
| Sept 2021 | - | $584.00 K(>+9900.0%) |
| June 2021 | - | $0.00(-100.0%) |
| Mar 2021 | - | $508.00 K(+120.9%) |
| Dec 2020 | $230.00 K(-73.9%) | $230.00 K(-13.2%) |
| Sept 2020 | - | $265.00 K(-24.7%) |
| June 2020 | - | $352.00 K(-75.6%) |
| Mar 2020 | - | $1.44 M(+63.9%) |
| Dec 2019 | $881.00 K(-31.0%) | $881.00 K(-32.3%) |
| Sept 2019 | - | $1.30 M(+113.4%) |
| June 2019 | - | $610.00 K(-62.2%) |
| Mar 2019 | - | $1.61 M(+26.3%) |
| Dec 2018 | $1.28 M(+94.1%) | $1.28 M(+5.2%) |
| Sept 2018 | - | $1.21 M(+12.0%) |
| June 2018 | - | $1.08 M(+13.3%) |
| Mar 2018 | - | $957.00 K(+45.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $658.00 K(+20.7%) | $658.00 K(+36.8%) |
| Sept 2017 | - | $481.00 K(-51.9%) |
| June 2017 | - | $1.00 M(-34.6%) |
| Mar 2017 | - | $1.53 M(+180.4%) |
| Dec 2016 | $545.00 K(+8.8%) | $545.00 K(-62.4%) |
| Sept 2016 | - | $1.45 M(-39.7%) |
| June 2016 | - | $2.40 M(+211.5%) |
| Mar 2016 | - | $771.00 K(+53.9%) |
| Dec 2015 | $501.00 K(-10.5%) | $501.00 K(-66.3%) |
| Sept 2015 | - | $1.49 M(+66.3%) |
| June 2015 | - | $895.00 K(-10.9%) |
| Mar 2015 | - | $1.00 M(+79.3%) |
| Dec 2014 | $560.00 K(-42.3%) | $560.00 K(-61.5%) |
| Sept 2014 | - | $1.45 M(+46.5%) |
| June 2014 | - | $992.00 K(-23.2%) |
| Mar 2014 | - | $1.29 M(+33.1%) |
| Dec 2013 | $971.00 K(+19.4%) | $971.00 K(+1.9%) |
| Sept 2013 | - | $953.00 K(+17.2%) |
| Dec 2012 | $813.00 K(-48.4%) | $813.00 K |
| Dec 2011 | $1.58 M | - |
FAQ
- What is Concert Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Concert Pharmaceuticals?
What is Concert Pharmaceuticals annual accounts payable?
The current annual accounts payable of CNCE is $2.61 M
What is the all time high annual accounts payable for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high annual accounts payable is $2.61 M
What is Concert Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of CNCE is $2.75 M
What is the all time high quarterly accounts payable for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high quarterly accounts payable is $2.75 M